Anogenital cancers testing in San Giovanni in Marignano
Find health labs to test for Anogenital cancers in San Giovanni in Marignano and compare all offers by prices and services.
Tests that cover Anogenital cancers
HPV Test
Pap Test by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
test HPV cavo orale autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
Pap Smear by Laboratorio Lifebrain
Via Daijiro Kato, 10 c/o Misano World Cirucit 47843 Misano Adriatico (Rimini)
2.6 km
Pap Smear by Synlab
Piazza della Repubblica, 6, 47841 Cattolica RN, Italia
2.3 km
Pap Smear by Laboratorio Lifebrain
Via della Repubblica, 122 47843 Misano Adriatico (Rimini)
2.6 km
Pap Test by Poliambulatorio Exis - Centro Medico Fisioterapico e Riabilitativo
Via Roma, 7, 47833 Morciano di Romagna RN, Italia
3.7 km
Pap Smear by Synlab
Viale Panoramica, 35, 47838 Riccione RN, Italia
5.1 km
Pap Smear by Laboratorio Lifebrain
Via Ottorino Respighi, 54 61122 Pesaro (PU)
10.2 km
Pap Smear by Laboratorio Lifebrain
Via Castelfidardo, 85, P 61121 Pesaro (PU)
10.2 km
Pap Smear by Synlab
Via Melozzo da Forlì, 6, 47923 Rimini RN, Italia
11.1 km
Pap Smear by Synlab
Corso Giovanni XXIII, 114, 47921 Rimini RN, Italia
11.1 km
Pap Smear by Synlab
Viale Principe Amedeo, 11, 47921 Rimini RN, Italia
11.1 km
Anogenital cancers - symptoms and how to test
Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.
